Exosens SAS (EXENS.PA) stock: key figures, P/E, revenue and dividend

Industrials · France · ISIN FR001400Q9V2

Price
57.10 EUR
Market cap
2.90 bn EUR
P/E (2025)
194.74
P/S (2025)
6.19
Dividend yield
0.53 %
Net margin
8.97 %
Return on equity (ROE)
9.42 %
Return on assets (ROA)
4.78 %

Exosens SAS financials

Fiscal year20242025
Revenue394.00 m EUR468.00 m EUR
Gross profit225.00 m EUR102.00 m EUR
Operating income80.58 m EUR104.10 m EUR
EBIT76.00 m EUR102.00 m EUR
Net income30.00 m EUR42.00 m EUR
Diluted EPS – continuing operations0.72 EUR0.29 EUR

Full history since 2020, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Exosens SAS

Exosens, together with its subsidiaries, develops, manufactures, and sells electro-optical technologies in France, Europe, North America, Asia, and internationally. It operates in two segments, Amplification and Detection and Imaging. The company offers image intensifier tubes; cameras, sensors, modules and cores, and imaging systems and solutions, including UV missile warning solution, atmospheric sounder, and spectroradiometer; and detection and imaging products for ions and electrons, photons, and neutrons, as well as micro pore optics and components, such as phosphor screens, resistive glass products, microchannel plates, and electron generator arrays. It also provides bare and energy compensated Geiger- Müller tubes; gamma and neutron detectors; mineral insulated extensions; and silicon photodiodes, as well as methane airborne detection solutions. The company sells its products under the Exosens, Photonis, Xenics, Telops, El-Mul, and Noxant brand names. It serves defense and surveillance, life sciences and environment, industrial control, and nuclear markets. The company was founded in 1937 and is headquartered in Mérignac, France.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.